BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10377492)

  • 1. [Evaluation of a new automated method for von Willebrand factor antigen measurement: the STA-Liatest vWF].
    Veyradier A; Fressinaud E; Sigaud M; Wolf M; Meyer D
    Ann Biol Clin (Paris); 1999 May; 57(3):364-8. PubMed ID: 10377492
    [No Abstract]   [Full Text] [Related]  

  • 2. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO; Van Cott EM
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.
    De Vleeschauwer A; Devreese K
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):353-8. PubMed ID: 16788311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.
    Studt JD; Budde U; Schneppenheim R; Eisert R; von Depka Prondzinski M; Ganser A; Barthels M
    Am J Clin Pathol; 2001 Oct; 116(4):567-74. PubMed ID: 11601142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options.
    Favaloro EJ
    Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures.
    Sucker C; Senft B; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):305-10. PubMed ID: 16959683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of collagen-binding assay for von Willebrand disease].
    Zhou J; Jia YQ; Jiang H; Yang YM; Deng CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP; Erb HN; Catalfamo JL
    Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Performance of a New Immunoturbidimetric Assay for von Willebrand Factor (VWF) Activity Testing.
    Louw S; Wan YO; Mayne ES; Mahlangu JN
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.